Oncocyte Corp.
13F holders, Q3 2024 (September 30)1holders −1
0new positions
1sold out
$2.85avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Oncocyte Corp. in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Defender Capital, LLC. ($169K).
- Company
- Oncocyte Corp.
- CUSIP
- 68235C107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3.2M |
All 13F filers, Q2 2024 → Q3 2024: 4,133 shares bought and 1,097,175 shares sold, net −1,093,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Defender Capital, LLC. | 0.06% | Add +7.5% | 59,353 | $169K |
"% of holder's portfolio" is ONCOCYTE CORP's weight in each manager's 13F, not the share of Oncocyte Corp. the manager owns.